Compugen Ltd. (CGEN)
Company Info
| ISIN | IL0010852080 |
|---|---|
| CUSIP | M25722105 |
| Sector | Healthcare |
| Industry | Biotechnology |
| IPO Date | Aug 11, 2000 |
Highlights
| Market Cap | $157.82M |
|---|---|
| EPS (TTM) | -$0.09 |
| Total Revenue (TTM) | $42.72M |
| Gross Profit (TTM) | $37.06M |
| EBITDA (TTM) | $6.08M |
| Year Range | $0.61 - $3.03 |
| Target Price | $5.00 |
| Short % | 1.79% |
| Short Ratio | 7.50 |
Share Price Chart
Loading data...
Compare to other instruments
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Popular comparisons: CGEN vs. VOO, CGEN vs. SGMO
Performance
Performance Chart
The chart shows the growth of an initial investment of $10,000 in Compugen Ltd., comparing it to the performance of the S&P 500 index or another benchmark. All prices have been adjusted for splits and dividends.
Returns By Period
Compugen Ltd. had a return of -24.75% year-to-date (YTD) and 141.53% in the last 12 months. Over the past 10 years, Compugen Ltd. had an annualized return of -13.64%, while the S&P 500 had an annualized return of 11.31%, indicating that Compugen Ltd. did not perform as well as the benchmark.
| Period | Return | Benchmark |
|---|---|---|
| Year-To-Date | -24.75% | 24.72% |
| 1 month | -8.59% | 2.30% |
| 6 months | -30.37% | 12.31% |
| 1 year | 141.53% | 32.12% |
| 5 years (annualized) | -23.42% | 13.81% |
| 10 years (annualized) | -13.64% | 11.31% |
Monthly Returns
The table below presents the monthly returns of CGEN, with color gradation from worst to best to easily spot seasonal factors. Returns are adjusted for dividends.
| Jan | Feb | Mar | Apr | May | Jun | Jul | Aug | Sep | Oct | Nov | Dec | Total | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2024 | 21.72% | 7.05% | -0.00% | -25.19% | 12.44% | -22.58% | 5.36% | 18.64% | -13.81% | -11.60% | -24.75% | ||
| 2023 | 21.39% | -9.05% | -11.16% | -15.95% | 72.88% | 11.76% | 1.75% | -1.72% | -18.42% | -18.28% | -12.80% | 198.78% | 176.65% |
| 2022 | -17.44% | -12.96% | 4.21% | -26.09% | -22.27% | 0.00% | -12.97% | -27.33% | -43.85% | 44.87% | 26.08% | -40.36% | -83.36% |
| 2021 | 0.41% | -23.27% | -7.93% | 0.47% | -11.01% | 7.81% | -18.00% | 3.39% | -14.96% | 8.71% | -31.90% | -2.71% | -64.49% |
| 2020 | 20.81% | 25.97% | -19.96% | 99.59% | 6.21% | -2.40% | -4.06% | 19.99% | -6.02% | -20.68% | -0.39% | -5.69% | 103.19% |
| 2019 | 58.99% | -0.29% | 20.35% | -15.46% | -20.00% | 37.14% | -15.62% | 18.83% | 9.87% | 21.28% | 18.71% | -2.13% | 174.65% |
| 2018 | 20.00% | 33.33% | 11.25% | -21.35% | 7.14% | -12.00% | -4.55% | 23.81% | -1.28% | -20.00% | 12.34% | -37.28% | -13.20% |
| 2017 | -6.86% | -10.53% | 1.18% | -5.81% | 18.52% | -20.83% | 6.58% | -24.69% | 24.59% | -21.05% | -18.33% | 2.04% | -50.98% |
| 2016 | -26.29% | 0.85% | 17.47% | 21.51% | 2.65% | -6.90% | 2.62% | 5.71% | -10.38% | -8.73% | 5.22% | -15.70% | -20.19% |
| 2015 | -6.84% | 7.73% | -15.67% | -9.08% | 10.45% | -1.98% | -11.53% | -19.87% | 5.08% | 19.73% | 22.78% | -15.92% | -23.29% |
| 2014 | 20.89% | 4.81% | -7.32% | -10.85% | -13.55% | 10.99% | -5.23% | 4.46% | -3.71% | -16.69% | -2.38% | 19.51% | -6.93% |
| 2013 | 10.16% | -0.55% | -5.94% | 18.15% | -2.50% | -7.02% | -2.58% | 83.55% | 5.66% | -2.53% | 3.90% | -13.86% | 81.91% |
Risk-Adjusted Performance
Risk-Adjusted Performance Rank
The current risk-adjusted rank of CGEN is 83, placing it in the top 17% of stocks on our website in terms of risk-adjusted performance. This ranking is based on the combined values of the indicators listed below.
Risk-Adjusted Performance Indicators
The charts below present risk-adjusted performance metrics for Compugen Ltd. (CGEN) and compare them to a chosen benchmark (^GSPC). These indicators evaluate an investment's returns against its associated risks.
Dividends
Dividend History
Drawdowns
Drawdowns Chart
The Drawdowns chart displays portfolio losses from any high point along the way. Drawdowns are calculated considering price movements and all distributions paid, if any.
Worst Drawdowns
The table below displays the maximum drawdowns of the Compugen Ltd.. A maximum drawdown is a measure of risk, indicating the largest reduction in portfolio value due to a series of losing trades.
The maximum drawdown for the Compugen Ltd. was 97.90%, occurring on Nov 24, 2008. Recovery took 2953 trading sessions.
The current Compugen Ltd. drawdown is 92.34%.
Depth | Start | To Bottom | Bottom | To Recover | End | Total |
|---|---|---|---|---|---|---|
| -97.9% | Sep 6, 2000 | 2066 | Nov 24, 2008 | 2953 | Aug 19, 2020 | 5019 |
| -97.28% | Aug 26, 2020 | 810 | Nov 13, 2023 | — | — | — |
| -15.03% | Aug 15, 2000 | 4 | Aug 18, 2000 | 2 | Aug 22, 2000 | 6 |
| -2.06% | Aug 20, 2020 | 1 | Aug 20, 2020 | 3 | Aug 25, 2020 | 4 |
| -1% | Aug 24, 2000 | 1 | Aug 24, 2000 | 1 | Aug 25, 2000 | 2 |
Volatility
Volatility Chart
The current Compugen Ltd. volatility is 16.09%, representing the average percentage change in the investments's value, either up or down over the past month. The chart below shows the rolling one-month volatility.
Financials
Financial Performance
Historical P/E Ratio Chart
The chart below displays the historical trend of the price-to-earnings (P/E) ratio for Compugen Ltd..
Loading data...
Income Statement
| TTM | |
|---|---|
| Revenue | |
Total Revenue | — |
Cost Of Revenue | — |
Gross Profit | — |
| Operating Expenses | |
Selling, General & Admin Expenses | — |
R&D Expenses | — |
Depreciation And Amortization | — |
Total Operating Expenses | — |
| Income | |
Income Before Tax | — |
Operating Income | — |
EBITDA | — |
EBIT | — |
Earnings From Continuing Operations | — |
Net Income | — |
Income Tax Expense | — |
Other Non-Operating Income (Expenses) | — |
Extraordinary Items | — |
Discontinued Operations | — |
Effect Of Accounting Charges | — |
Non Recurring | — |
Minority Interest | — |
Other Items | — |
Interest Income | — |
Interest Expense | — |
Net Interest Income | — |